Brooke Pierce appointed President of DLH's Health business group to enhance federal health solutions and strategy.
Quiver AI Summary
DLH Holdings Corp. has appointed Brooke Pierce as President of its Health division, effective September 14, 2026. In her new role, Pierce will oversee the company's health business, focusing on technology, scientific research, data analytics, and support services for federal health markets. With nearly 20 years of experience leading large federal programs, including those for major health agencies, Pierce is recognized for her contributions to innovation in federal Health IT and has successfully managed significant revenue-generating IT programs. DLH President & CEO Kathryn JohnBull emphasized that Pierce's expertise will be crucial in advancing the company's health strategy and enhancing organizational performance. DLH Holdings Corp. is committed to providing advanced solutions across technology and public health sectors to improve mission outcomes for federal customers.
Potential Positives
- Appointment of Brooke Pierce as President of Health strengthens DLH's leadership and strategic focus in the health sector.
- Ms. Pierce's nearly 20 years of experience in federal health programs highlights the company's commitment to operational excellence and innovation.
- Her proven track record in leading large-scale healthcare IT initiatives positions DLH to enhance its service offerings and drive growth in federal health markets.
Potential Negatives
- Appointment of a new president may indicate instability or past leadership shortcomings in the health division.
- Forward-looking statements include significant risks and uncertainties that could affect future financial performance.
- Potential concerns over the company's ability to manage competition and retain employees and customers are highlighted.
FAQ
Who has been appointed as President of Health at DLH Holdings Corp.?
Brooke Pierce has been appointed President of Health at DLH Holdings Corp. effective September 14, 2026.
What will Brooke Pierce's role entail at DLH?
She will lead the Health business group, focusing on technology, scientific research, and mission-support services for federal health markets.
What experience does Brooke Pierce bring to DLH?
Brooke Pierce brings nearly 20 years of experience in large-scale federal programs, including notable health organizations like NIH and CMS.
How will Brooke Pierce impact DLH's health strategy?
Her experience in building high-performing health organizations will strengthen execution and advance DLH’s health strategy and growth initiatives.
What is DLH Holdings Corp. primarily focused on?
DLH focuses on providing digital, engineering, and scientific solutions for health and defense missions, enhancing technology and cybersecurity readiness.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DLHC Insider Trading Activity
$DLHC insiders have traded $DLHC stock on the open market 54 times in the past 6 months. Of those trades, 54 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $DLHC stock by insiders over the last 6 months:
- BROOK ASSET MANAGEMENT LLC MINK has made 54 purchases buying 173,988 shares for an estimated $925,569 and 0 sales.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$DLHC Revenue
$DLHC had revenues of $44.2M in Q3 2026. This is a decrease of -46.94% from the same period in the prior year.
You can track DLHC financials on Quiver Quantitative's DLHC stock page.
You can access data on DLHC stock through the Quiver Quantitative API.
$DLHC Hedge Fund Activity
We have seen 14 institutional investors add shares of $DLHC stock to their portfolio, and 21 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MINK BROOK ASSET MANAGEMENT LLC added 138,541 shares (+5.2%) to their portfolio in Q2 2026, for an estimated $727,340
- ANSON FUNDS MANAGEMENT LP added 20,011 shares (+inf%) to their portfolio in Q2 2026, for an estimated $105,057
- GOLDMAN SACHS GROUP INC added 13,618 shares (+inf%) to their portfolio in Q2 2026, for an estimated $71,494
- BLACKROCK, INC. added 13,136 shares (+18.2%) to their portfolio in Q2 2026, for an estimated $68,964
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 13,000 shares (-26.9%) from their portfolio in Q2 2026, for an estimated $68,250
- MILLENNIUM MANAGEMENT LLC removed 12,986 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $75,578
- RENAISSANCE TECHNOLOGIES LLC removed 11,691 shares (-6.0%) from their portfolio in Q2 2026, for an estimated $61,377
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
ATLANTA, Sept. 14, 2026 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of digital, engineering, and scientific solutions for health and defense missions, today announced that Brooke Pierce has been appointed President, Health, effective September 14, 2026.
In this role, Ms. Pierce will lead the Company’s Health business group, encompassing work in technology, scientific research, data analytics, artificial intelligence, and mission-support services across federal health markets. She will be responsible for advancing the strategic direction and growth of DLH’s health portfolio, while ensuring operational execution, deepening customer engagement, and fostering employee development.
Ms. Pierce brings nearly 20 years of experience leading large-scale federal programs, including health missions spanning the National Institutes of Health (“NIH”), the Centers for Medicare & Medicaid Services (“CMS”), the Food and Drug Administration (“FDA”), the Substance Abuse & Mental Health Services Administration (“SAMHSA”), the Centers for Disease Control and Prevention (“CDC”), as well as the commercial healthcare market. In her role supporting CMS, she was recognized with a FedHealthIT100 Award for advancing innovation and transformation in federal Health IT.
Ms. Pierce most recently provided executive leadership for an enterprise IT program generating more than $600 million in annual revenue. In that role, she directed a team of approximately 2,000 employees delivering cybersecurity, cloud services, and AI-enabled modernization across hundreds of global sites supporting millions of users. Previous roles include leading a large federal health organization with responsibility for a $350 million portfolio and approximately 600 employees in support of CMS and a team delivering clinical, financial, and operational systems in the commercial healthcare market.
“Brooke’s experience building high-performing health and technology organizations that deliver operational excellence to customers, profitable growth, and organizational development at scale will be invaluable as we advance DLH’s health strategy,” said DLH President & CEO Kathryn JohnBull. “Her record leading complex federal health and technology organizations will strengthen execution across our portfolio. We are thrilled to welcome Brooke to DLH and look forward to the leadership and perspective she will bring to our customers, our employees, and our organization.”
About DLH
DLH (NASDAQ: DLHC) enhances technology, public health, and cyber security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With a world-class workforce dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com .
Contact Information:
Investor Relations
Media
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward-looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding the anticipated use of proceeds. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements due to a variety of factors, including: the failure to achieve the anticipated benefits of any future acquisition (including anticipated future financial operating performance and results); the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; significant delays or reductions in appropriations for our programs and broader changes in U.S. government funding and spending patterns; legislation that amends or changes discretionary spending levels or budget priorities; legal, regulatory, and political changes from the federal government that could result in economic uncertainty; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2025, as well as interim quarterly filings thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business. Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements.
